Samia Boussouar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samia Boussouar has a total of 233 co-authors. Here are the top co-authors by number of shared publications:
- Alban Redheuil
Sorbonne University, Department of Cardiovascular and Thoracic Radiology, Hôpital de la Pitié-Salpêtrière (AP-HP), Institute of Cardiometabolism and Nutrition (ICAN), Paris, France; Sorbonne University, Biomedical Imaging Laboratory (LIB), INSERM, CNRS, Institute of Cardiometabolism and Nutrition (ICAN), Paris, France
83 shared publications - Marc Pineton De Chambrun
Service de Médecine Intensive-Réanimation, Sorbonne Université, Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital La Pitié–Salpêtrière, Paris Cedex, France
79 shared publications - Adrien Procureur
Sorbonne University, APHP, INSERM, CIC-1901, Hopital Pitié-Salpétrière, 75013 Paris, France
78 shared publications - Alexandre Demoule
INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Sorbonne Université, Paris, France
78 shared publications - Aude Rigolet
12Sorbonne Université, INSERM, Department of Internal Medicine, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France
78 shared publications - Baptiste Abbar
Centre d'Immunologie et des Maladies Infectieuses (CIMI-Paris), Institut national de la santé et de la recherche médicale (INSERM), Sorbonne University, Paris, France; Department of Medical Oncology, Assistance Publique-Hôpitaux de Paris (AP-HP), Pitié-Salpêtrière Hospital, Institut Universitaire de Cancérologie, Sorbonne University, Paris, France
78 shared publications
Latest Publications
- Open Access
- 13 November 2026
- Published by Elsevier in Radiotherapy and Oncology
Impact of chemical depletion of club cells on the pulmonary response to irradiation in mice
- 13 November 2026
- Published by Elsevier in Radiotherapy and Oncology
Open AccessImpact of chemical depletion of club cells on the pulmonary response to irradiation in mice
- 31 October 2026
- Published by Elsevier in Journal d'imagerie diagnostique et interventionnelle
Maladie d’Erdheim-Chester : aspect en imagerie
- 31 October 2026
- Published by Elsevier in Journal d'imagerie diagnostique et interventionnelle
Maladie d’Erdheim-Chester : aspect en imagerie
- Open Access
- 16 October 2026
- Published by Springer Nature in European Radiology Experimental
- Vol. 10 (1) , 159
Fully automated diaphragm segmentation on routine 2D-cine and 3D thoracic MRI: multireader validation
Objective: The diaphragm is central to respiratory mechanics and may be impaired in various diseases. Parametric magnetic resonance imaging (MRI) assessment is limited by time-consuming manual segmentation. We developed and validated fully automated diaphragm segmentation on two-dimensional (2D)-cine and three-dimensional (3D) thoracic MRI. Materials and methods: In this single-center study, eligible adults without known diaphragmatic disorders underwent 2D-cine MRI, 3D MRI, or both. Two U-Net models (2D/3D) were trained using expert manual contours as ground truth. Performance was evaluated with normalized surface Dice (NSD) with 3-voxel tolerance and average surface distance (ASSD). In the main cohort, five blinded radiologists rated segmentation usability and image quality. An additional separate pathology cohort was assessed by two blinded readers using the same scale. Results: Overall, 59 individuals contributed 70 MRI acquisitions: 29 women, 30 men; aged 49.3 ± 18.8 years (mean ± standard deviation). Inference required 5 s (2D) and 30 s (3D) versus 10 min and 4.5 h for manual annotation. Segmentation accuracy was high: NSD 0.95 ± 0.08 (2D) and 0.92 ± 0.06 (3D), with ASSD 1.97 ± 2.29 mm (2D) and 1.88 ± 1.97 mm (3D). In the main cohort, segmentations were rated clinically usable in 87.5% (2D) and 100% (3D). Mean image-quality scores were 4.0/5 (2D) and 4.2/5 (3D) and correlated with segmentation quality. In the pathology cohort ( n = 5), segmentation usability for 2D images was 75% for reader 1 and 70% for reader 2 for 2D images and 80% for both readers for 3D volumes. Conclusion: Automated diaphragm segmentation on 2D-cine and 3D MRI is feasible, accurate, and time-efficient, supporting scalable, standardized diaphragm analysis as a basis for deriving diaphragm biomarkers. Key Points: Question Can fully automated diaphragm segmentation make routine 2D-cine and 3D thoracic MRI analysis clinically feasible by replacing time-consuming manual delineation? Findings Automated segmentation achieved normalized surface Dice above 0.9, radiologist acceptability in 87.5–100% of cases, and inference times below 30 s Relevance statement Automated diaphragm segmentation on routine 2D-cine and 3D static MRI yields accurate, radiologist-acceptable segmentations with normalized surface Dice exceeding 0.9 and mean surface deviations below 2 mm. This approach may support standardized diaphragm assessment for objective quantification in thoracic and neuromuscular imaging pending larger multicenter validation.
- 16 October 2026
- Published by Springer Nature in European Radiology Experimental
- Vol. 10 (1) , 159
Open AccessFully automated diaphragm segmentation on routine 2D-cine and 3D thoracic MRI: multireader validation
Objective: The diaphragm is central to respiratory mechanics and may be impaired in various diseases. Parametric magnetic resonance imaging (MRI) assessment is limited by time-consuming manual segmentation. We developed and validated fully automated diaphragm segmentation on two-dimensional (2D)-cine and three-dimensional (3D) thoracic MRI. Materials and methods: In this single-center study, eligible adults without known diaphragmatic disorders underwent 2D-cine MRI, 3D MRI, or both. Two U-Net models (2D/3D) were trained using expert manual contours as ground truth. Performance was evaluated with normalized surface Dice (NSD) with 3-voxel tolerance and average surface distance (ASSD). In the main cohort, five blinded radiologists rated segmentation usability and image quality. An additional separate pathology cohort was assessed by two blinded readers using the same scale. Results: Overall, 59 individuals contributed 70 MRI acquisitions: 29 women, 30 men; aged 49.3 ± 18.8 years (mean ± standard deviation). Inference required 5 s (2D) and 30 s (3D) versus 10 min and 4.5 h for manual annotation. Segmentation accuracy was high: NSD 0.95 ± 0.08 (2D) and 0.92 ± 0.06 (3D), with ASSD 1.97 ± 2.29 mm (2D) and 1.88 ± 1.97 mm (3D). In the main cohort, segmentations were rated clinically usable in 87.5% (2D) and 100% (3D). Mean image-quality scores were 4.0/5 (2D) and 4.2/5 (3D) and correlated with segmentation quality. In the pathology cohort ( n = 5), segmentation usability for 2D images was 75% for reader 1 and 70% for reader 2 for 2D images and 80% for both readers for 3D volumes. Conclusion: Automated diaphragm segmentation on 2D-cine and 3D MRI is feasible, accurate, and time-efficient, supporting scalable, standardized diaphragm analysis as a basis for deriving diaphragm biomarkers. Key Points: Question Can fully automated diaphragm segmentation make routine 2D-cine and 3D thoracic MRI analysis clinically feasible by replacing time-consuming manual delineation? Findings Automated segmentation achieved normalized surface Dice above 0.9, radiologist acceptability in 87.5–100% of cases, and inference times below 30 s Relevance statement Automated diaphragm segmentation on routine 2D-cine and 3D static MRI yields accurate, radiologist-acceptable segmentations with normalized surface Dice exceeding 0.9 and mean surface deviations below 2 mm. This approach may support standardized diaphragm assessment for objective quantification in thoracic and neuromuscular imaging pending larger multicenter validation.
- Open Access
- 13 October 2026
- Published by Springer Nature in BMC Medical Imaging
Feasibility of automated quantitative CT imaging metrics in pulmonary Langerhans cell histiocytosis: a pilot study
- 13 October 2026
- Published by Springer Nature in BMC Medical Imaging
Open AccessFeasibility of automated quantitative CT imaging metrics in pulmonary Langerhans cell histiocytosis: a pilot study
- 18 September 2026
- Published by Wiley in Hematological Oncology
- Vol. 44 (5) , e70260
CBL Variants in Suspected Histiocytic Neoplasms: A Retrospective Study of 11 Cases
- 18 September 2026
- Published by Wiley in Hematological Oncology
- Vol. 44 (5) , e70260
CBL Variants in Suspected Histiocytic Neoplasms: A Retrospective Study of 11 Cases
- 26 February 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 254, 108735
Diffuse alveolar hemorrhage in antiphospholipid syndrome: Clinical presentation and prognosis
- 26 February 2026
- Published by Elsevier in Respiratory Medicine
- Vol. 254, 108735
Diffuse alveolar hemorrhage in antiphospholipid syndrome: Clinical presentation and prognosis
- Open Access
- 26 February 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
AI-based chest CT quantification of interstitial lung disease in idiopathic inflammatory myopathies: agreement with expert visual assessment in 107 patients
Background: Interstitial lung disease (ILD) is a determinant of morbidity and mortality in idiopathic inflammatory myopathies (IIM), but chest HRCT evaluation remains observer-dependent. Artificial intelligence (AI) may provide reproducible quantitative assessment. We compared AI-based quantification of ILD with expert visual scoring in IIM. Methods: In this monocentric retrospective study, 107 patients with IIM-associated ILD from a national myositis registry were included. One representative chest HRCT per patient was evaluated by a thoracic radiologist using a semi-quantitative lobar score and by a commercially available AI tool for lung texture analysis. AI-derived volumes were converted to the same 5-point scale as the visual score. Correlations were assessed with Spearman coefficients and agreement with Cohen’s kappa. Results: All CTs were suitable for visual assessment and 106/107 (99%) for AI analysis. AI identified ground-glass opacities (GGO) as the predominant abnormality, with a lower-lobe predominance. Correlations between AI and radiologist scores were strong for normal lung ( r = 0.77) and moderate for GGO ( r = 0.64) and consolidation ( r = 0.60), but weaker for reticulations ( r = 0.34) and honeycombing ( r = 0.42). Agreement was good for GGO (κ = 0.70) and consolidation (κ = 0.60), moderate for reticulations (κ = 0.37) and low for honeycombing (κ = 0.16). Conclusion: In IIM-associated ILD, AI-based chest HRCT quantification showed good agreement with expert visual assessment, particularly for GGO and consolidation, but was less reliable for complex fibrotic patterns. AI may support more objective and reproducible evaluation of interstitial involvement, as a complement to expert interpretation.
- 26 February 2026
- Published by Springer Nature in BMC Pulmonary Medicine
- Vol. 26 (1)
Open AccessAI-based chest CT quantification of interstitial lung disease in idiopathic inflammatory myopathies: agreement with expert visual assessment in 107 patients
Background: Interstitial lung disease (ILD) is a determinant of morbidity and mortality in idiopathic inflammatory myopathies (IIM), but chest HRCT evaluation remains observer-dependent. Artificial intelligence (AI) may provide reproducible quantitative assessment. We compared AI-based quantification of ILD with expert visual scoring in IIM. Methods: In this monocentric retrospective study, 107 patients with IIM-associated ILD from a national myositis registry were included. One representative chest HRCT per patient was evaluated by a thoracic radiologist using a semi-quantitative lobar score and by a commercially available AI tool for lung texture analysis. AI-derived volumes were converted to the same 5-point scale as the visual score. Correlations were assessed with Spearman coefficients and agreement with Cohen’s kappa. Results: All CTs were suitable for visual assessment and 106/107 (99%) for AI analysis. AI identified ground-glass opacities (GGO) as the predominant abnormality, with a lower-lobe predominance. Correlations between AI and radiologist scores were strong for normal lung ( r = 0.77) and moderate for GGO ( r = 0.64) and consolidation ( r = 0.60), but weaker for reticulations ( r = 0.34) and honeycombing ( r = 0.42). Agreement was good for GGO (κ = 0.70) and consolidation (κ = 0.60), moderate for reticulations (κ = 0.37) and low for honeycombing (κ = 0.16). Conclusion: In IIM-associated ILD, AI-based chest HRCT quantification showed good agreement with expert visual assessment, particularly for GGO and consolidation, but was less reliable for complex fibrotic patterns. AI may support more objective and reproducible evaluation of interstitial involvement, as a complement to expert interpretation.
- Open Access
- 5 February 2026
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 47 (4) , 213-223
Diagnostic radiologique d’une pneumopathie interstitielle
- 5 February 2026
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 47 (4) , 213-223
Open AccessDiagnostic radiologique d’une pneumopathie interstitielle
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Figure S1 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
Examples of cardiac and skeletal muscle pathology findings on autopsies of 2 patients
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
Examples of cardiac and skeletal muscle pathology findings on autopsies of 2 patients
- Open Access
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Table S6 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
Treatment modalities and reported adverse events by quartile of period of inclusion.
- 11 December 2025
- Published by American Association for Cancer Research (AACR)
Open AccessTable S6 from Abatacept/Ruxolitinib and Screening for Concomitant Respiratory Muscle Failure to Mitigate Fatality of Immune-Checkpoint Inhibitor Myocarditis
Treatment modalities and reported adverse events by quartile of period of inclusion.